Skip to main content

Biophysics-Based Markers Surpassing Biochemical Markers in Screening of Ageing-Related Neurodegeneration and Cognitive Impairment

  • Conference paper
  • First Online:
Healthcare Engineering

Abstract

Historically the first biomarker to distinguish abnormal from normal tissue was biophysical properties, such as elasticity of tissue or viscosity of body fluids. Based on the stiffness or percussion of organs, clinical medicine formulated numerous useful diagnostic signs. Indeed, biophysical parameters such as elasticity and viscosity are some of the basic parameters of transport and mobility processes in a system. The value of the shear elasticity modulus of abnormal tissue is known to be up to 10–30 times that of normal tissue, whereas values of biochemical concentrations generally differ at most within 2–5 times ostensibly to preserve metabolic homeostasis. Hence, there is a need for an easily-affordable noninvasive methodology that could estimate elasticity and effusivity in tissue, especially for the brain, which is encased in bony enclosures, thereby providing considerable scope for using elastometric/effusiometric measurements to diagnose disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fiandaca MS, et al. The critical need for defining preclinical biomarkers in Alzheimer’s disease. Alzheimer’s & Dementia. 2014;10(3), (Suppl): S196–S212.

    Google Scholar 

  2. Wattamwar PR, et al. An overview of biomarkers in Alzheimer’s disease. Annals of Indian Academy of Neurology. 2010;13, (Suppl2): S116–S123.

    Google Scholar 

  3. Riemenschneider MM, et al. Cerebrospinal Fluid Tau and β-Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment. Archives of Neurology. 2002;59(11): 1729–1734.

    Google Scholar 

  4. Ramaswamy, R., R. Khanna, and P. K. Roy. Topological Connectivity and Elastic Responsivity of Brain as a window to the Alzheimer-type Neurodegenerative process. (in communication).

    Google Scholar 

  5. Mapstone M, et al. Nature Medicine. 2014;20: 415–418.

    Google Scholar 

  6. Roberts A.P. Morphology and thermal conductivity of model organic aerogels. Physical Review E. 1997;55: R1286–R1289.

    Google Scholar 

  7. Madadi M, et al. 3D Imaging and simulation of elastic properties of porous materials. Computing in Science and Engineering. 2009: 65–73.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajiv Ramaswamy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this paper

Cite this paper

Ramaswamy, R., Khanna, R., Roy, P. (2017). Biophysics-Based Markers Surpassing Biochemical Markers in Screening of Ageing-Related Neurodegeneration and Cognitive Impairment. In: Shorey, R., Ghosh, P. (eds) Healthcare Engineering. Springer, Singapore. https://doi.org/10.1007/978-981-10-3111-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-3111-3_11

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-3110-6

  • Online ISBN: 978-981-10-3111-3

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics